
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised alarm over the discovery of a falsified antibiotic, BETACLOX (Ampicillin 250mg and Cloxacillin 250mg), circulating in Nigeria’s drug market.
In a statement issued on Monday, the agency said the product was detected after a retail outlet in Zaria, Kaduna State, reported a suspicious batch purchased from a distributor in Kano. Preliminary findings revealed that the NAFDAC registration number printed on the fake product actually belongs to another medicine entirely, Mebendazole 500mg, produced by Chi Ltd., indicating deliberate misrepresentation.
The agency warned that the falsified antibiotic poses a major risk to public health, as it may contain unknown or harmful substances instead of the approved formulation.

Further investigation showed that the counterfeit product, allegedly imported by “Freeview Pharmaceutical Ltd.,” carries a falsified address. The packaging lists No. 128 MCC Road, Calabar, Cross River State, but NAFDAC confirmed that the genuine Freeview Pharmaceutical Ltd. is registered at No. 101 MCC Road, Calabar. This, the agency said, suggests identity theft and unauthorized use of the company’s details.

Also read: NAFDAC Seizes ₦170m Worth of Toxic Cosmetics, Shuts 10 Shops in Abuja Crackdown
The fake antibiotic was reportedly manufactured by “Saeny Laboratory Pvt. Ltd.” based in Kerala, India. Its batch number is 230701, with a manufacturing date of July 2023 and expiry date of July 2026. It also bears a forged registration number, A4-4724.
In response, NAFDAC has ordered all its zonal directors and state coordinators to intensify surveillance and seize any falsified BETACLOX products found in circulation. The agency also urged pharmacists, distributors, and healthcare providers to buy only from licensed suppliers and to scrutinize packaging and labels for authenticity before dispensing.

Consumers have been advised to immediately report any suspicious drugs to the nearest NAFDAC office or through the agency’s toll-free line.
“Public safety remains our top priority,” the agency said, urging Nigerians to remain vigilant against counterfeit medicines.
The agency published the alert, tagged Public Alert No. 37/2025, on its official website and social media handles to further warn the public.